CoreCivic, Inc. (CXW) Stock Price & How to Invest

CoreCivic, based in Nashville, owns, leases and operates correctional, detention and residential reentry facilities under contract with government agencies. It is paid mainly a per diem rate for each resident housed each day, which makes occupancy and contracted bed counts the two numbers that drive results. Its customers are US Immigration and Customs Enforcement, the US Marshals Service, state departments of correction, and county and local governments. Residential occupancy was 78.4% in the second quarter of 2026, up from 76.8% a year earlier. The company also leases real estate to government tenants and, since April 2026, owns a correctional pharmacy business bought for about $199.8 million that serves more than 600 facilities across 32 states.

The investment picture in 2026 has two moving parts. The first is growth: federal detention spending has let CoreCivic reactivate idle facilities including Dilley, California City, Diamondback and, from August 2026, the 1,600-bed Prairie Correctional Facility in Minnesota that had been empty since 2010, and five recently activated sites alone produced $80.1 million of revenue and $21.1 million of operating income in the second quarter. The second is a balance-sheet reset: CoreCivic sold four facilities to the Department of Homeland Security for roughly $2.2 billion gross, used $608.5 million of it to repay debt, and expanded its buyback authorization to $1.2 billion. The catch is that selling the real estate while continuing to manage the sites converts owned-and-operated economics into lower-margin management fees, which is why full-year adjusted EBITDA guidance came down even as revenue grew. CoreCivic gave up its REIT status effective January 2021, is taxed as an ordinary C corporation, and has paid no dividend since 2020.

The concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. A 2021 executive order directing the Justice Department not to renew private prison contracts removed CoreCivic's Bureau of Prisons business, a worked example of how fast policy can subtract revenue, and several states including California, Illinois, New Jersey and Washington restrict private detention outright. ESG exclusion is a structural overhang rather than a headline problem: numerous funds screen the sector out and several large banks stopped lending to private prison operators after 2019, which narrows both the shareholder base and financing options, and was part of the backdrop to the REIT exit. Selling facilities to DHS raises cash but leaves CoreCivic managing beds it no longer owns, which lowers margins and shortens the tie between the company and the assets. Staffing costs, occupancy swings, litigation and reputational scrutiny round out the operating risks.

5 analysts publish price targets on CXW, averaging $41.00 against a $33.60 price as of August 2026, or +22.0%. The published targets run from $36.00 to $45.00, a narrow spread, and the ratings split 4 buy, 0 hold, 0 sell. Over the last six months there have been 5 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CXW forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on CoreCivic, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Reactivating idle beds. The clearest earnings lever is turning facilities that were sitting empty back into contracted, occupied capacity. The most optimistic published target, $45.00, assumes this works close to its best case.

The case against. The concentration risk is unusually direct: roughly half of revenue comes from two federal agencies whose budgets and enforcement posture change with administrations, and government contracts here typically run in short terms with termination-for-convenience provisions. The most pessimistic target, $36.00, is roughly what CXW is worth if this bites instead.

Read the full bull and bear case on CXW, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see CoreCivic, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$2.48B
• Q2 2026 revenue: ~$684.9M (+27.3% YoY)
• FY2026 adjusted diluted EPS guidance: ~$1.62 to $1.70
• FY2026 adjusted EBITDA guidance: ~$440.5M to $445.5M (cut from ~$453.8M to $461.8M)
• Total debt after repayments: ~$739M (after repaying ~$608.5M)
• Market cap: ~$3.3B

The headline GAAP numbers for 2026 are distorted by the DHS transactions: guided diluted EPS of about $15.00 to $15.20 reflects a roughly $1.8 billion one-time gain, while adjusted diluted EPS of about $1.62 to $1.70 is the figure that describes the ongoing business. At a share price near $33.60 in mid-August 2026, that puts the stock around 20 times the midpoint of adjusted earnings, with a much smaller debt load than the company carried a year earlier. The detail worth noting is that adjusted EBITDA guidance was reduced even as revenue guidance rose, because facilities sold to DHS shift from owned-and-operated to managed-only, and ICE had not yet modified those management contracts to reflect the ownership change at the time of the report.

Other names that sit close to CXW: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CXW exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CXW sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CXW fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

CXW is a policy-driven operator with about half its revenue tied to two federal agencies, where the case rests on how long the current detention build-out lasts and what the company does with the cash it just raised.

Whether CXW is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CXW a buy or a sell?, and where the stock could go from here in the CXW stock forecast.

For income investors, whether CXW pays a dividend and how the payout looks is covered in does CXW pay a dividend? And to weigh CXW against a peer, read the full side-by-side comparisons: CXW vs GEO and CXW vs ICE.